These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35104166)

  • 1. Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears.
    Kanapka LG; Lum JW; Beck RW
    Diabetes Technol Ther; 2022 Jun; 24(6):396-402. PubMed ID: 35104166
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears: Response to Letter to Editor.
    Kanapka LG; Lum JW; Beck RW
    Diabetes Technol Ther; 2022 Aug; 24(8):601-602. PubMed ID: 35913845
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized trial of infusion set function: steel versus teflon.
    Patel PJ; Benasi K; Ferrari G; Evans MG; Shanmugham S; Wilson DM; Buckingham BA
    Diabetes Technol Ther; 2014 Jan; 16(1):15-9. PubMed ID: 24090124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.
    Cescon M; DeSalvo DJ; Ly TT; Maahs DM; Messer LH; Buckingham BA; Doyle FJ; Dassau E
    J Diabetes Sci Technol; 2016 Nov; 10(6):1268-1276. PubMed ID: 27621142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.
    Schmid V; Hohberg C; Borchert M; Forst T; Pfützner A
    J Diabetes Sci Technol; 2010 Jul; 4(4):976-82. PubMed ID: 20663464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.
    Brazg R; Garg SK; Bhargava A; Thrasher JR; Latif K; Bode BW; Bailey TS; Horowitz BS; Cavale A; Kudva YC; Kaiserman KB; Grunberger G; Reed JC; Chattaraj S; Zhang G; Shin J; Chen V; Lee SW; Cordero TL; Rhinehart AS; Vigersky RA; Buckingham BA
    Diabetes Technol Ther; 2022 Aug; 24(8):535-543. PubMed ID: 35263188
    [No Abstract]   [Full Text] [Related]  

  • 7. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.
    Karlin AW; Ly TT; Pyle L; Forlenza GP; Messer L; Wadwa RP; DeSalvo DJ; Payne SL; Hanes S; Clinton P; Maahs DM; Buckingham B
    Diabetes Technol Ther; 2016 Jul; 18(7):429-35. PubMed ID: 27227290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and Detection of Insulin Infusion Site Failure in the Type 1 Diabetes Exchange Online Community.
    Hughes MS; Douvas JL; Layfield-Bryan M; Blanco LE; Gray JC; Zapotoczny G; Espinoza J; Wilcox JH; Lal RA
    Diabetes Technol Ther; 2023 Jun; 25(6):426-430. PubMed ID: 36856574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
    Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
    Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.
    Chase HP; Doyle FJ; Zisser H; Renard E; Nimri R; Cobelli C; Buckingham BA; Maahs DM; Anderson S; Magni L; Lum J; Calhoun P; Kollman C; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):623-32. PubMed ID: 25188375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.
    Pickup JC; Yemane N; Brackenridge A; Pender S
    Diabetes Technol Ther; 2014 Mar; 16(3):145-9. PubMed ID: 24180294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility study of a prototype extended-wear insulin infusion set in adults with type 1 diabetes.
    Kastner JR; Venkatesh N; Brown K; Muchmore DB; Ekinci E; Fourlanos S; Joseph JI; Shafeeq M; Shi L; Strange P; Strasma PJ; O'Neal DN
    Diabetes Obes Metab; 2022 Jun; 24(6):1143-1149. PubMed ID: 35257468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
    Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
    [No Abstract]   [Full Text] [Related]  

  • 17. In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time.
    Kastner JR; Eisler G; Torjman MC; Khalf A; Diaz D; Dinesen AR; Loeum C; Strasma PJ; Joseph JI
    J Diabetes Sci Technol; 2023 Nov; 17(6):1563-1572. PubMed ID: 35533132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes.
    Murphy HR; Elleri D; Allen JM; Harris J; Simmons D; Rayman G; Temple R; Dunger DB; Haidar A; Nodale M; Wilinska ME; Hovorka R
    Diabetes Care; 2011 Feb; 34(2):406-11. PubMed ID: 21216859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study.
    Bode BW; Garg SK; Norwood P; Morales C; Hardy T; Liu R; Ignaut D
    Diabetes Technol Ther; 2021 Jan; 23(1):41-50. PubMed ID: 32640842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.